Abstract:Introduction: Gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NENs) are malignancies originating from cells of the diffuse endocrine system. They are rare and localize in the upper and lower parts of the gastrointestinal tract and in the pancreas. Despite such a varied location, GEP-NENs are considered a common group of neoplasms due to the fact of their similar morphology and ability to secrete peptide hormones and biologically active amines. They are associated with clinical manifestations specific to the substances produced by a particular neoplasm. The classification of GEP-NENs is constantly systematized and updated based on their differentiation and grading. The development of available diagnostic and treatment methods for these tumors has made significant progress over the past 10 years and is still ongoing.Aim: In the following paper, we review the diagnostics and treatment of GEP-NENs, taking into account the latest molecular, immunological, or gene-based methods. Imaging methods using markers for receptors allow for high diagnostic sensitivityMethods: Medical databases were searched for the latest information. The authors also sought confirmation of the content of a particular publication in another publications, so as to present the most reliable information possible.Results: Research results revealed that the diagnostics and treatment of GEP-NENs have significantly advanced in recent years. Surgical interventions, especially minimally invasive techniques, have shown efficacy in treating GEP-NENs, with specific therapies such as somatostatin analogs, chemotherapy, and peptide receptor radionuclide therapy demonstrating promising outcomes. The evolution of diagnostic methods, including imaging techniques and biomarker testing, has contributed to improved patient care and prognosis.Conclusions: The increasing incidence of GEP-NENs is attributed to enhanced diagnostic capabilities rather than a rise in population prevalence. The study emphasizes the importance of ongoing research to identify specific markers for early detection and targeted therapies to further enhance the effectiveness of treating these rare and heterogeneous malignancies. The findings suggest a positive trajectory in the management of GEP-NENs, with future prospects focused on personalized and targeted treatment approaches.

Renewal of ideas and focus of gastroenteropancreatic neuroendocrine neoplasm

Role of Surgical Treatments in High-Grade or Advanced Gastroenteropancreatic Neuroendocrine Neoplasms.

New insights in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Gastroenteropancreatic neuroendocrine neoplasms: epidemiology, genetics, and treatment

Gastroenteropancreatic neuroendocrine neoplasms: current development, challenges, and clinical perspectives

Gastroenteropancreatic Neuroendocrine Neoplasms：concepts and Related Issues

Diagnosis and Treatment of Gastrointestinal Neuroendocrine Neoplasm in the Multidisciplinary Team Model

Role of multidisciplinary team in the diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NENs) - Current literature review of diagnostics and therapy. What has changed in the management?

[The Diagnosis and Treatment of Pancreatic Neuroendocrine Neoplasms].

Analysis of The Diagnosis and Treatment of Gastroenteropancreatic Neuroendocrine Neoplasm in 70 Cases

Advances and Pathological Diagnostic Standard of Gastroenteropancreatic Neuroendocrine Neoplasms

[Implementation of Multidisciplinary Team in the Diagnosis and Treatment of Gastroenteropancreatic Neuroendocrine Neoplasm].

Modern strategy for the management of gastroenteropancreatic neuroendocrine neoplasm liver metastases

[Consensus and controversy of endoscopic diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors]

The Advance in Research into Immunotherapy for Neuroendocrine Carcinoma of Digestive System

Strategies of neoadjuvant and conversion therapy for gastroenteropancreatic neuroendocrine neoplasms

Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology

Biomarkers to Inform Prognosis and Treatment for Unresectable or Metastatic GEP-NENs

The comprehensive treatment of metastatic pancreatic neuroendocrine tumors

Consensus and controversy of pathological diagnosis of gastrointestinal and pancreatic neuroendocrine neoplasms